369 related articles for article (PubMed ID: 31427375)
1. A20 at the Crossroads of Cell Death, Inflammation, and Autoimmunity.
Martens A; van Loo G
Cold Spring Harb Perspect Biol; 2020 Jan; 12(1):. PubMed ID: 31427375
[TBL] [Abstract][Full Text] [Related]
2. A20 and Cell Death-driven Inflammation.
Priem D; van Loo G; Bertrand MJM
Trends Immunol; 2020 May; 41(5):421-435. PubMed ID: 32241683
[TBL] [Abstract][Full Text] [Related]
3. A20/Tumor Necrosis Factor α-Induced Protein 3 in Immune Cells Controls Development of Autoinflammation and Autoimmunity: Lessons from Mouse Models.
Das T; Chen Z; Hendriks RW; Kool M
Front Immunol; 2018; 9():104. PubMed ID: 29515565
[TBL] [Abstract][Full Text] [Related]
4. Roles of A20 in autoimmune diseases.
Zhang M; Peng LL; Wang Y; Wang JS; Liu J; Liu MM; Hu J; Song B; Yang HB
Immunol Res; 2016 Apr; 64(2):337-44. PubMed ID: 26135958
[TBL] [Abstract][Full Text] [Related]
5. Single nucleotide polymorphisms at the TNFAIP3/A20 locus and susceptibility/resistance to inflammatory and autoimmune diseases.
Mele A; Cervantes JR; Chien V; Friedman D; Ferran C
Adv Exp Med Biol; 2014; 809():163-83. PubMed ID: 25302371
[TBL] [Abstract][Full Text] [Related]
6. O-Linked β-N-Acetylglucosamine Modification of A20 Enhances the Inhibition of NF-κB (Nuclear Factor-κB) Activation and Elicits Vascular Protection After Acute Endoluminal Arterial Injury.
Yao D; Xu L; Xu O; Li R; Chen M; Shen H; Zhu H; Zhang F; Yao D; Chen YF; Oparil S; Zhang Z; Gong K
Arterioscler Thromb Vasc Biol; 2018 Jun; 38(6):1309-1320. PubMed ID: 29622561
[TBL] [Abstract][Full Text] [Related]
7. DNGR1-mediated deletion of A20/Tnfaip3 in dendritic cells alters T and B-cell homeostasis and promotes autoimmune liver pathology.
Das T; Bergen IM; Koudstaal T; van Hulst JAC; van Loo G; Boonstra A; Vanwolleghem T; Leung PSC; Gershwin ME; Hendriks RW; Kool M
J Autoimmun; 2019 Aug; 102():167-178. PubMed ID: 31151831
[TBL] [Abstract][Full Text] [Related]
8. A20 in inflammation and autoimmunity.
Catrysse L; Vereecke L; Beyaert R; van Loo G
Trends Immunol; 2014 Jan; 35(1):22-31. PubMed ID: 24246475
[TBL] [Abstract][Full Text] [Related]
9. A novel missense mutation in TNFAIP3 causes haploinsufficiency of A20.
Jiang W; Deng M; Gan C; Wang L; Mao H; Li Q
Cell Immunol; 2022 Jan; 371():104453. PubMed ID: 34808442
[TBL] [Abstract][Full Text] [Related]
10. Preserving immune homeostasis with A20.
Razani B; Malynn BA; Ma A
Adv Immunol; 2020; 148():1-48. PubMed ID: 33190732
[TBL] [Abstract][Full Text] [Related]
11. Vitamin E δ-tocotrienol inhibits TNF-α-stimulated NF-κB activation by up-regulation of anti-inflammatory A20 via modulation of sphingolipid including elevation of intracellular dihydroceramides.
Yang C; Jiang Q
J Nutr Biochem; 2019 Feb; 64():101-109. PubMed ID: 30471562
[TBL] [Abstract][Full Text] [Related]
12. Current research into A20 mediation of allergic respiratory diseases and its potential usefulness as a therapeutic target.
Liu Y; Xu K; Yao Y; Liu Z
Front Immunol; 2023; 14():1166928. PubMed ID: 37056760
[TBL] [Abstract][Full Text] [Related]
13. A20: a jack of all trades.
Hertens P; van Loo G
Trends Cell Biol; 2024 May; 34(5):360-362. PubMed ID: 38461099
[TBL] [Abstract][Full Text] [Related]
14. The ubiquitin-editing enzyme A20 (TNFAIP3) is a central regulator of immunopathology.
Vereecke L; Beyaert R; van Loo G
Trends Immunol; 2009 Aug; 30(8):383-91. PubMed ID: 19643665
[TBL] [Abstract][Full Text] [Related]
15. B cells lacking the tumor suppressor TNFAIP3/A20 display impaired differentiation and hyperactivation and cause inflammation and autoimmunity in aged mice.
Chu Y; Vahl JC; Kumar D; Heger K; Bertossi A; Wójtowicz E; Soberon V; Schenten D; Mack B; Reutelshöfer M; Beyaert R; Amann K; van Loo G; Schmidt-Supprian M
Blood; 2011 Feb; 117(7):2227-36. PubMed ID: 21088135
[TBL] [Abstract][Full Text] [Related]
16. RNF31 mediated ubiquitination of A20 aggravates inflammation and hepatocyte apoptosis through the TLR4/MyD88/NF-κB signaling pathway.
Li S; Zheng X; Hu Y; You K; Wang J
Chem Biol Interact; 2021 Oct; 348():109623. PubMed ID: 34416243
[TBL] [Abstract][Full Text] [Related]
17. Haploinsufficiency of A20 Due to Novel Mutations in TNFAIP3.
He T; Huang Y; Luo Y; Xia Y; Wang L; Zhang H; Ling J; Yang J
J Clin Immunol; 2020 Jul; 40(5):741-751. PubMed ID: 32514655
[TBL] [Abstract][Full Text] [Related]
18. Interplay of Toll-Like Receptor 9, Myeloid Cells, and Deubiquitinase A20 in Periodontal Inflammation.
Crump KE; Oakley JC; Xia-Juan X; Madu TC; Devaki S; Mooney EC; Sahingur SE
Infect Immun; 2017 Jan; 85(1):. PubMed ID: 27849177
[TBL] [Abstract][Full Text] [Related]
19. A20, an essential component of the ubiquitin-editing protein complex, is a negative regulator of inflammation in human myometrium and foetal membranes.
Lappas M
Mol Hum Reprod; 2017 Sep; 23(9):628-645. PubMed ID: 28911210
[TBL] [Abstract][Full Text] [Related]
20. The ubiquitin modifying enzyme A20 restricts B cell survival and prevents autoimmunity.
Tavares RM; Turer EE; Liu CL; Advincula R; Scapini P; Rhee L; Barrera J; Lowell CA; Utz PJ; Malynn BA; Ma A
Immunity; 2010 Aug; 33(2):181-91. PubMed ID: 20705491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
